Introduction

Physical urticaria represents a diverse group of inducible hypersensitivity disorders that pose significant diagnostic and therapeutic challenges due to variability in triggers and patient responses.

Aim

This research investigates the effectiveness of various treatment modalities for physical urticaria, a collection of conditions triggered by physical stimuli like cold, heat, pressure, vibration, and solar radiation.

Methods

This article reviews different types of physical urticaria, their diagnostic approaches, and current treatment strategies, analysing the efficacy of antihistamines, corticosteroids, omalizumab, benralizumab, ligelizumab, desensitisation, immunosuppressive agents, and phototherapy, with special attention given to provocation tests, which play a key role in diagnosis and monitoring patient responses to specific stimuli.

Results

Emerging therapies, such as omalizumab, have shown encouraging results in chronic spontaneous urticaria and are being explored for physical urticaria. These therapies report a significant reduction in symptom severity and frequency in a subset of patients unresponsive to conventional treatments. While antihistamines are a key part of treatment, their shortcomings in severe cases show why it is important to look for other options and additional treatments. The findings of this study provide an evidence-based framework for clinicians to optimise diagnostic strategies and select personalised treatment approaches depending on the type of physical urticaria and patient response, thereby improving clinical decision-making and patient outcomes.

Conclusions

A personalised approach to treatment, incorporating advanced diagnostic methods and targeted therapies, is essential for improving patient outcomes and quality of life in individuals with physical urticaria, suggesting the potential for improved management strategies with further research.